First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.Éric Baudin, Piero Ferollà, Alfredo Berruti et al.|Journal of Clinical Oncology|2021Cited by 7